#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperphagia Glomerulonephritis chronic Krabbe's disease Neuroendocrine carcinoma metastatic Hyperadrenocorticism Hypocalcaemia Philadelphia positive acute lymphocytic leukaemia Stargardt's disease Transient ischaemic attack Acromegaly Dementia Alzheimer's type Osteogenesis imperfecta Short-bowel syndrome Mucopolysaccharidosis I Hodgkin's disease recurrent More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Basic Information Bronchiolitis obliterans syndrome – Life with Disease Mantle cell lymphoma – Life with Disease Sarcoidosis Primary mediastinal large B-cell lymphoma – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Mucous membrane pemphigoid – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Treatment Pulmonary fibrosis – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4527226 Varnimcabtagene Autoleucel L-PROLINE Allopurinol Mebendazole Ursodoxicoltaurine Lisocabtagene Maraleucel Op-1250 Tilsotolimod Sodium Darunavir Avatrombopag Aavanc80-5'Hotof 18F-Fludarabine Defactinib Streptococcus Agalactiae HYDROXYCHLOROQUINE Aliskiren Fosaprepitant Brigatinib Caba-201 More therapies…

    Learn about Your Condition

    Herpes zoster Mite allergy Primary biliary cholangitis Dementia with Lewy bodies Epidermolysis bullosa Catatonia Periodontitis Plasma cell myeloma refractory Anal cancer recurrent Metastases to meninges Clostridium difficile colitis Renal cell carcinoma stage IV Skin neoplasm excision Respiratory failure Bronchopulmonary aspergillosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Title: Evaluation of optimal timing for heparin anticoagulation in patients undergoing transseptal heart procedures (TEER or left atrial appendage closure)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Mitral valve incompetence
    • Atrial fibrillation
    Investigated Drugs:
    • Heparin Sodium
    Poland

  • Study of acetylsalicylic acid and clopidogrel treatment after left atrial appendage closure in patients with atrial fibrillation and chronic kidney disease

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    Poland

  • Study on Teprenone for Preventing Atrial Fibrillation After Heart Surgery in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Teprenone
    The Netherlands

  • Study on Spironolactone for Maintaining Sinus Rhythm in Hypertensive Patients with Atrial Fibrillation and Preserved Heart Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Micronised Spironolactone
    France

  • Study on Flecainide and Amiodarone for Treating Atrial Fibrillation in Patients with Coronary Artery Disease and Ejection Fraction Over 35%

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Coronary artery disease
    Investigated Drugs:
    • Flecainide Acetate
    • Amiodarone Hydrochloride
    Greece

  • Study on Monitoring Anticoagulant Therapy with Rivaroxaban and Warfarin in Patients with Acute Coronary Syndrome and Atrial Fibrillation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Atrial fibrillation
    Investigated Drugs:
    • Rivaroxaban
    • Warfarin Sodium
    France
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!